What could a new disease activity score for polymyalgia rheumatica do better?
- PMID: 33257871
- DOI: 10.1038/s41584-020-00550-6
What could a new disease activity score for polymyalgia rheumatica do better?
Comment in
-
Reply to: What could a new disease activity score for polymyalgia rheumatica do better?Nat Rev Rheumatol. 2021 Mar;17(3):185-186. doi: 10.1038/s41584-020-00551-5. Nat Rev Rheumatol. 2021. PMID: 33257870 No abstract available.
Comment on
-
Monitoring and long-term management of giant cell arteritis and polymyalgia rheumatica.Nat Rev Rheumatol. 2020 Sep;16(9):481-495. doi: 10.1038/s41584-020-0458-5. Epub 2020 Aug 5. Nat Rev Rheumatol. 2020. PMID: 32759996 Review.
References
-
- Camellino, D., Matteson, E. L., Buttgereit, F. & Dejaco, C. Monitoring and long-term management of giant cell arteritis and polymyalgia rheumatica. Nat. Rev. Rheumatol. 16, 481–495 (2020). - DOI
-
- Leeb, B. F. & Bird, H. A. A disease activity score for polymyalgia rheumatica. Ann. Rheum. Dis. 63, 1279–1283 (2004). - DOI
-
- Leeb, B. F. et al. EULAR response criteria for polymyalgia rheumatica: results of an initiative of the European Collaborating Polymyalgia Rheumatica Group (subcommittee of ESCISIT). Ann. Rheum. Dis. 62, 1189–1194 (2003). - DOI
-
- Mackie, S. L. et al. The OMERACT core domain set for outcome measures for clinical trials in polymyalgia rheumatic. J. Rheumatol. 44, 1515–1521 (2017). - DOI
-
- Smolen, J. S. et al. A simplified disease activity index for rheumatoid arthritis for use in clinical practice. Rheumatology 42, 244–257 (2003). - DOI
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
